A notable stride forward involves a pioneering clinical trial, backed by government funding, that seeks to delve into the potential of utilizing psilocybin in gambling addiction treatment. The Mirror reports this endeavor as the world’s first-ever clinical trial of its kind, underscoring its groundbreaking nature and the novelty it brings to the field.